Top Markets
Coin of the day
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock

Polaryx Therapeutics, Inc. Common Stock

PLYX
Rank in Stocks #21586
Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to... Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to advancing small-molecule therapies for lysosomal storage and neurodegenerative conditions. Its developmental pipeline includes a trio of promising candidates: PLX-100, which combines PLX-200 with an ancillary supplement, targeting late infantile neuronal ceroid lipofuscinosis (LINCL) and related forms of NCL. PLX-200, a repurposed compound already utilized to address various diseases in both adult and pediatric populations. And PLX-300, derived from an edible plant, which works by activating PPARa to enhance the production of transcription factor EB. The company, established in 2014, maintains its base of operations in Paramus, New Jersey.
Share Price
$2.10
Last synced: 2026-08-21
Market Cap
$104.43M
Change (1 day)
-2.10%
Change (1 year)
-
Country
US
Trade Polaryx Therapeutics, Inc. Common Stock (PLYX)

Category

Stock split history for Polaryx Therapeutics, Inc. Common Stock (PLYX)
Polaryx Therapeutics, Inc. Common Stock stock (symbol: PLYX) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 23, 2026.
One PLYX share bought prior to Aug 23, 2026 would equal to 0 PLYX shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH